Navigation Links
Siemens Launches Motion(TM), a Complete Product Portfolio for Mild Through Severe Hearing Loss
Date:10/31/2008

ntclair, New Jersey. "Now, they are so confident, where before they might have kept to themselves and felt self-conscious about their hearing impairment. 'I can hear, I can do anything anyone else can do.' And with Tek, you can do it better."

Motion is the latest product that reflects Siemens ongoing commitment to make every hearing solution as individual as the person who wears it.

"Each case of hearing loss is as different as the person affected," says Dr. Thomas Powers, Vice-President of Audiology and Professional Relations at Siemens Hearing Instruments, Inc. "Some wearers prefer a more hidden behind-the-ear hearing instrument, and others might prefer an in-the-ear solution. Some of these choices are dictated audiologically, of course, but others are a matter of lifestyle and personal preference. The technology today is so advanced that the options for any hearing solution are many, and are directly influenced the wearer."

Technology in Motion

Siemens built into the Motion line of hearing instruments the natural sound technology and design features attractive to wearers who seek to simplify the daily maintenance of their hearing loss. For example, Motion is available with algorithms ( or advanced signal processing) such as SoundLearning(TM) and DataLearning(R) that remember sound quality and volume settings, and eWindScreen(R) that continually analyzes incoming signals to detect wind noise, then automatically adjusts signal processing to reduce it. All Motion behind-the-ear instruments can be fully charged in five hours in a specially designed optional charger, eliminating the need to buy and replace batteries. Following are highlights of a few more of the many advanced features available with Motion:

SoundSmoothing(R) by Siemens is the industry-leading transient noise suppression technology (such as the sound of utensils while eating, or the noise of a closing door or rustling paper) that can increase the wearer's satisfaction
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Siemens Extends Tender Offer for Acquisition of Dade Behring
2. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
3. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
4. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
5. VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
6. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
7. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. VIDEO from Medialink and Siemens: Worlds Smallest Ultrasound Package Launches in the U.S.
10. Siemens Soarian Health Information Management is Widely Adopted by Leading Healthcare Institutions in 2007
11. James Cracknell Launches Siemens Stroke for Stroke Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...IGHTS, Mich., Dec. 4 The Editorial...erInvesting Magazine today announced Allergan, I... Study" and C.R. Bard, Inc. (NYSE: BCR ) as it... informational and educational use. ,, "The com...ies involving its flagship drug Botox and other pr...
(Date:12/4/2009)...4 While Congress debate...care costs, Leapfrog,s purchaser members point to ...ng the best quality care in the nation while attai... urban, eight children,s and three rural hospitals...d on results from The Leapfrog Hospital Survey. ,...
(Date:12/4/2009)... some pediatric cancers, particularly Ewing sarcom...ding to a new study published online December 4 in..., This study was undertaken because there is limi... up to 20 years) for pediatric cancer patients. ,...er Center and Blood Disorders Service, Children,s ...
(Date:12/4/2009)...ts at Johns Hopkins publishing in the December iss...y a gene called "Twist" may be the proverbial red ...at drive aggressive, metastatic breast cancer from... work suggesting that it is a relatively rare subg...east cancer, scientists have surmised that this su...
(Date:12/4/2009)...ans are recruited annually to participate in clini...earch Protection (AHRP), and most will be compensa...itutions view payments to volunteers as compensati...potential risks related to participating in the ex...have a very different view of clinical trial compe...
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Human guinea pigs wary of high-paying medical trials 2
... Sept. 5 Traditional Latin,American foods have a ...,many of these foods that have brought families to...ays that can compromise one,s health. Oftentimes ..., eating foods high in fat and calories can place ...
...ember 4, 2007) Today, the Canadian Institutes of ...omote public access to the results of research it ...nsure that their original research articles are fr... is essential for advancing knowledge and accelera...
... TriWest Healthcare Alliance is,offering an innov...families,who have lost a loved one in service to o...ard and Reserve unit commanders, TriWest is partne...s-kind partnership, TriWest and Steen will offer,"...
...t. 4 HEI, Inc. (Nasdaq: HEII,-- http://www.heii....le of,substantially all of the assets of its RFID ...-owned subsidiary of Dutch based Smartrac N.V. The...mer lists, and the assumption of substantially all...
...e Technology Executive Brings Over 20 Years Of Exp...ional Excellence, LENEXA, Kan., Sept. 4 /PRNewswi..., (Nasdaq: MEDW ) announced the appointment of Th...y,division where he held a wide range of senior ma...
...y Jeremy Graff and colleagues from Eli Lilly and C...a new therapeutic in a mouse model of human tumors...ty of this therapeutic to treat human cancers. As ... effective in clinical trials as it was in mice it...
Other Medicine News:Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Open access to health research publications 2Health News:TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program 2Health News:HEI, Inc. Closes on Sale of RFID Division Assets 2Health News:Mediware Names Thomas K. Mann Chief Executive Officer 2Health News:It's a knock out: eIF4E-specific anti-sense oligonucleotides knock down cancer 2
(Date:12/4/2009)...f., Dec. 4 Suneva Medical, a priva...announced the appointment of Philip Ranker as Vice...ole, Mr. Ranker will lead all Suneva Medical,s gen...e, accounting, IT, IR, administration and human re...or management team. ,, "One of my key objectiv...
(Date:12/4/2009)....Y., Dec. 4 Bayer Diabetes Care to...er,s "Express Your Simple Win Creativity Contest."...inning video entries submitted by children with di... an in-person meeting today with Nick. ,, The... Caleb, age 6, from Danbury, CT, who dreams of bec...
(Date:12/4/2009)...Dec. 4 Depression, anxiety disorde...ty Disorder (ADHD), sleep disorder and migraine: T... more often in people who said they had been diagn...y diagnosis, according to a survey of approximatel...s from " CNS-Related Comorbidities in Individuals ...
Breaking Medicine Technology:Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Dangerous college drinking 3A Prevention is possible studies suggest 48834 1Dangerous college drinking 3A Prevention is possible studies suggest 48834 2Thomas McKeever to Spearhead Jackson 26amp 3B Coker 26apos 3Bs National Accounts Division 48829 1Thomas McKeever to Spearhead Jackson 26amp 3B Coker 26apos 3Bs National Accounts Division 48829 2Thomas McKeever to Spearhead Jackson 26amp 3B Coker 26apos 3Bs National Accounts Division 48829 3Aussie and Kiwi researchers make double MS genetic discovery 8821 1Aussie and Kiwi researchers make double MS genetic discovery 8821 2
... 25 The Quigley,Corporation (Nasdaq: QGLY ) toda...rd quarter ended September 30, 2007, compared to $... For the nine-months ended September,30, 2007, net...n reported,for the same period in 2006. The third...et sales,increase for the Company,s Cold Remedy se...
...e FDG-PET Imaging -, SAN FRANCISCO, Oct. 25 VIA ...company focused on the development of,compounds fo...ed today that,it will soon initiate a third Phase ... VIA-2291 targets inflammation in the blood vessel...its complications, including heart,attack and stro...
Other Medicine Technology:The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 2The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 3The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 4The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 5The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 6The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy 7VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome 2VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome 3VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome 4
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: